A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer

Title
A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 18, Issue 17, Pages 4820-4829
Publisher
American Association for Cancer Research (AACR)
Online
2012-07-06
DOI
10.1158/1078-0432.ccr-12-0098

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started